ArticleMolecules (Basel, Switzerland)2021

Scaffold Repurposing of In-House Small Molecule Candidates Leads to Discovery of First-in-Class CDK-1/HER-2 Dual Inhibitors: In Vitro and In Silico Screening.

Ahmed Elkamhawy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.